Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenograftsC Larbouret, B Robert, C Bascoul-Mollevi, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 29, 2019
[RadioTransNet, the French network for preclinical research in oncological radiotherapy]E Bayart, D Azria, J Balosso, et al.ESMO Real World Data and Digital Oncology|February 6, 2026
Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018)C Courtinard, V Barbet, R Schiappa, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 15, 2016
[Radiotherapy of breast cancer]C Hennequin, I Barillot, D Azria, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|August 1, 2023
Learning curve for robotic-assisted total mesorectal excision: a multicentre, prospective studyJ Arquillière, A Dubois, E Rullier, et al.The Pharmacogenomics Journal|July 21, 2010
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancerA Ho-Pun-Cheung, E Assenat, C Bascoul-Mollevi, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 15, 2020
[Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]I Latorzeff, P Sargos, G Créhange, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)M Ychou, J-L Raoul, J-Y Douillard, et al.Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 15, 2023
[Interprofessional recommendations on behalf of Société française de radiothérapie oncologique for the prevention, protection and management of cyberattacks in radiation oncology]P Giraud, B Fleury, C Le Prince, et al.The Journal of Urology|August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer CentersB Escudier, J P Droz, F Rolland, et al.Pageof 15